TrialBritish journal of cancer2022

Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancer.

Hiroyuki Arai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.